Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis

被引:203
作者
Ericson, KG
Fadeel, B
Nilsson-Ardnor, S
Söderhäll, C
Samuelsson, A
Janka, G
Schneider, M
Gürgey, A
Yalman, N
Révész, T
Egeler, RM
Jahnukainen, K
Storm-Mathiesen, I
Haraldsson, A
Poole, J
de Saint Basile, G
Nordenskjöld, M
Henter, JI
机构
[1] Karolinska Hosp, Dept Pediat Hematol & Oncol, Childhood Canc Res Unit, S-10401 Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden
[4] Umea Univ Hosp, Dept Clin Genet, S-90185 Umea, Sweden
[5] Childrens Univ Hosp, Dept Hematol & Oncol, Hamburg, Germany
[6] Univ Ulm, Ulm, Germany
[7] Hacettepe Univ, Dept Pediat Hematol, Ankara, Turkey
[8] Istanbul Sch Med, Dept Pediat Oncol, Istanbul, Turkey
[9] Wilhelmina Hosp Children, Dept Haematol, Utrecht, Netherlands
[10] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands
[11] Univ Turku, Dept Pediat, Turku, Finland
[12] Univ Oslo, Natl Hosp, Dept Pediat, Oslo, Norway
[13] Univ Hosp, Dept Paediat, Reykjavik, Iceland
[14] Johannesburg Hosp, Dept Paediat Haematol Oncol, Johannesburg, South Africa
[15] Hop Necker Enfants Malad, INSERM, Unite Rech Dev Normal & Pathol Syst Immunitaire, U429, Paris, France
关键词
D O I
10.1086/318796
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease of early childhood characterized by nonmalignant accumulation and multivisceral infiltration of activated T lymphocytes and histiocytes (macrophages). Cytotoxic T and natural killer (NK) cell activity is markedly reduced or absent in these patients, and mutations in a lytic granule constituent, perforin, were recently identified in a number of FHL individuals. Here, we report a comprehensive survey of 34 additional patients with FHL for mutations in the coding region of the perforin gene and the relative frequency of perforin mutations in FHL. Perforin mutations were identified in 7 of the 34 families investigated. Six children were homozygous for the mutations, and one patient was a compound heterozygote. Four novel mutations were detected: one nonsense, two missense, and one deletion of one amino acid. In four families, a previously reported mutation at codon 374, causing a premature stop codon, was identified, and, therefore, this is the most common perforin mutation identified so far in FHL patients. We found perforin mutations in 20% of all FHL patients investigated (7/34), with a somewhat higher prevalence, similar to 30% (6/20), in children whose parents originated from Turkey. No other correlation between the type of mutation and the phenotype of the patients was evident from the present study. Our combined results from mutational analysis of 34 families and linkage analysis of a subset of consanguineous families indicate that perforin mutations account for 20%-40% of the FHL cases and the FHL 1 locus on chromosome 9 for similar to 10%, whereas the major part of the FHL cases are caused by mutations in not-yet-identified genes.
引用
收藏
页码:590 / 597
页数:8
相关论文
共 34 条
  • [1] NATURAL CYTO-TOXICITY IMPAIRMENT IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
    ARICO, M
    NESPOLI, L
    MACCARIO, R
    MONTAGNA, D
    BONETTI, F
    CASELLI, D
    BURGIO, GR
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (03) : 292 - 296
  • [2] Proteases and cell-mediated cytotoxicity
    Darmon, AJ
    Bleackley, RC
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 1998, 18 (03) : 255 - 273
  • [3] ACTIVATION OF THE APOPTOTIC PROTEASE CPP32 BY CYTOTOXIC T-CELL-DERIVED GRANZYME-B
    DARMON, AJ
    NICHOLSON, DW
    BLEACKLEY, RC
    [J]. NATURE, 1995, 377 (6548) : 446 - 448
  • [4] Dufourcq-Lagelouse R, 1999, INT J MOL MED, V4, P127
  • [5] Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity
    Dufourcq-Lagelouse, R
    Jabado, N
    Le Deist, F
    Stéphan, JL
    Souillet, G
    Bruin, M
    Vilmer, E
    Schneider, M
    Janka, G
    Fischer, A
    Basile, GD
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) : 172 - 179
  • [6] Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors:: a single-centre experience of 12 patients
    Dürken, M
    Horstmann, M
    Bieling, P
    Erttmann, R
    Kabisch, H
    Löliger, C
    Schneider, EM
    Hellwege, HH
    Krüger, W
    Kröger, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (04) : 1052 - 1058
  • [7] Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis
    Egeler, RM
    Shapiro, R
    Loechelt, B
    Filipovich, A
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (04) : 340 - 345
  • [8] NATURAL-KILLER CELL-FUNCTION AND INTERFERON-PRODUCTION IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
    EIFE, R
    JANKA, GE
    BELOHRADSKY, BH
    HOLTMANN, H
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1989, 6 (03) : 265 - 272
  • [9] Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients
    Fadeel, B
    Orrenius, S
    Henter, JI
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 406 - 415
  • [10] FUJIWARA F, 1993, AM J PEDIAT HEMATOL, V15, P92